Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in <i>KMT2A</i> r and <i>NPM1</i> -m AML
Md. Hafiz Uddin(Wayne State University), Suresh Kumar Balasubramanian(Cleveland Clinic)
Cited by 0
Related Papers
Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells
|International Journal of Molecular Sciences|2021|12
Proteomic Analysis Identifies p62/SQSTM1 as a Critical Player in PARP Inhibitor Resistance
|Frontiers in Oncology|2022|7